ReviewNature reviews. Clinical oncology2026
Optimizing the delivery of radiotherapy with artificial intelligence.
Review in Nature reviews. Clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) and machine learning are transformative technologies that have sparked both excitement and concern. In radiation oncology, AI has been successfully applied to automate tasks, such as auto-contouring, geometric adaptation, calculation of radiation dose and quality assurance, and predicting outcomes to provide optimal patient care. The clinical deployment of AI-driven and machine learning-based tools, however, continues to lag behind their perceived potentials, owing to a range of technical, practical, ethical and legal concerns. The original predictive AI algorithms have been expanded with technologies such as generative AI and foundation models to enable new applications, such as automated treatment planning and synthetic computed tomography generation, as well as improved prediction of individual patient outcomes. The increasing availability of innovations such as agentic AI, digital twins and multimodal AI could further improve the delivery and, thus, the efficacy of radiotherapy. In this Review, we present examples of successful AI applications in radiation oncology, provide an overview of the current challenges for implementing such tools in this specialty and strategies for addressing them, and discuss the broader implications of these tools in optimizing treatment outcomes and the quality of patient care.
Identifiers
42778727What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.